SCHEMBL14299207

SCHEMBL14299207

CCO[Si](C#Cc1ccc2cc3ccccc3cc2c1)(OCC)OCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
ASIC3 Q9UHC3 2/20 0.36
ACACB O00763 1/20 0.34
CYP2A6 P11509 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
CDC25A P30304 1/20 0.33
CDC25B P30305 1/20 0.33
CDC25C P30307 1/20 0.33
DUSP3 P51452 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HBB P68871 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14299204 0.87 CYP1A2 (0.56) CYP1A2CYP1A1CYP1B1CYP2A6TDP1
SCHEMBL14299205 0.85 CYP1A2 (0.46) CYP1A2CYP1A1CYP1B1CYP2A6TDP1
SCHEMBL3946394 0.80 GRM5 (0.35) GRM5
SCHEMBL3947886 0.79 NQO1 (0.33)
SCHEMBL649394 0.79 NQO1 (0.32)
SCHEMBL15756940 0.79 CYP1A2 (0.41) CYP1A2CYP1A1CYP1B1ASIC3ACACB
SCHEMBL6562820 0.78 APP (0.42) CYP1A2GAAALDH1A1CYP3A4ALOX15
SCHEMBL649636 0.78 NQO1 (0.35) CYP1A2CYP2A6GAAALDH1A1
SCHEMBL14299202 0.76 NR1I2 (0.35) CYP1A2CYP1A1CYP1B1CYP2A6GAA
SCHEMBL14299203 0.76 NQO1 (0.32) GAAALDH1A1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9024053-B2 Compound obtained by dimerizing with light irradiation, a compound containing a group having lyophilicity, and a compound containing a group having liquid-repellency JOLED INC. (JP) 2015-05-05 US disclosed
US-8847211-B2 Device, thin film transistor, method for manufacturing the device and method for manufacturing the thin film transistor PANASONIC CORPORATION (JP) 2014-09-30 US disclosed
US-20120330047-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-27 US disclosed
US-20120319090-A1 DEVICE, THIN FILM TRANSISTOR, METHOD FOR MANUFACTURING THE DEVICE AND METHOD FOR MANUFACTURING THE THIN FILM TRANSISTOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120330047-A1 COMPOUND F10, CFD, INF2 CYP1A2 3855/4885CYP1A1 4300/4885CYP1B1 3506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.